NWPharmaTech is a Сlinical-Stage Biotechnology Company with a focus on Psychiatric & Neurological Disorders. Our expert team combines academic research, cutting-edge technology, and clinical development to bring to market new drug formulations targeting mental health conditions. These therapeutic interventions will support a return to homeostasis, empowering patients to lead longer and healthier lives. We are advancing to late-stage clinic development in two primary areas: Clinical High Risk for Psychosis & General Anxiety Disorder.
